Home » Topics » Regulatory » Patents

Patents
RSS

PEP inhibitors from Chinoin

April 14, 1997

Pfizer reports new salt of known NMDA antagonist

April 14, 1997

Synthelabo reports agents for urinary incontinence

April 11, 1997

Synthelabo prepares serotonergic agents

April 11, 1997

Arzneimittelwerk describes novel antiepileptic agents

April 11, 1997

Astra prepares NOS inhibitors

April 11, 1997

Antiviral dihydropyrans from Biota

April 11, 1997

Selective 5-HT1Dalpha receptor agonists from MS&D

April 11, 1997

beta-Lactamase inhibitors described by SynPhar

April 10, 1997

Dual H1/PAF antagonists disclosed by British Biotech

April 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for February 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...